TScan Therapeutics
Developing T cell therapies
- B2B
About TScan Therapeutics
Innovative biotech company developing T cell therapies for cancer treatment by identifying specific antigens that activate the immune system
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Waltham, Massachusetts, United States
- Founded
- 2018
- Revenue
- $10.3MFY2025, publicly reported
- Website
- tscan.com
TScan Therapeutics at a glance
TScan Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Waltham, Massachusetts, United States.
TScan Therapeutics was founded in 2018.
TScan Therapeutics has 51–250 employees.
TScan Therapeutics's revenue is $10.3M (FY2025, publicly reported).
Frequently asked questions about TScan Therapeutics
What is TScan Therapeutics's revenue?
TScan Therapeutics's revenue is $10.3M (FY2025, publicly reported).
How many employees does TScan Therapeutics have?
TScan Therapeutics has 51–250 employees.
Where is TScan Therapeutics headquartered?
TScan Therapeutics is headquartered in Waltham, Massachusetts, United States.
Selling to companies like TScan Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies